4//SEC Filing
Booth Andrew 4
Accession 0001209191-21-064378
CIK 0001703057other
Filed
Nov 14, 7:00 PM ET
Accepted
Nov 15, 6:05 AM ET
Size
7.2 KB
Accession
0001209191-21-064378
Insider Transaction Report
Form 4
Booth Andrew
Chief Financial Officer
Transactions
- Purchase
Common Shares
2021-11-11$14.61/sh+14,000$204,540→ 130,959 total(indirect: By Spouse) - Purchase
Common Shares
2021-11-11$14.74/sh+53,500$788,590→ 53,500 total
Footnotes (2)
- [F1]The price reported in Column 4 is a weighted-average price. These shares were sold in two transactions at prices $14.60 and $14.67. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F2]The price reported in Column 4 is a weighted-average price. These shares were sold in two transactions at prices $14.67 and $14.75. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Documents
Issuer
AbCellera Biologics Inc.
CIK 0001703057
Entity typeother
Related Parties
1- filerCIK 0001834411
Filing Metadata
- Form type
- 4
- Filed
- Nov 14, 7:00 PM ET
- Accepted
- Nov 15, 6:05 AM ET
- Size
- 7.2 KB